Aprocitentan-D4 is a deuterium-labeled Aprocitentan. Aprocitentan (T7817) is a major and pharmacologically active metabolite of Macitentan. Aprocitentan (T7817) is a dual ETA/ETB antagonist (IC50s: 3.4 nM and 987 nM; pA2s: 6.7 and 5.5).
Bexarotene-D4 is a deuterium-labeled Bexarotene (T6410) (LGD1069). Bexarotene is a selective RXR agonist used in the treatment of cutaneous T-cell lymphoma.
Cetirizine-D4 is a deuterium-labeled Cetirizine. Cetirizine (T0089L) is a second-generation antihistamine and a long-acting histamine H1-receptor antagonist.
Dabigatran-D4 hydrochloride is deuterium-labeled dabigatran,which is a reversible and selective direct thrombin inhibitor (DTI)with a Ki value of 4.5 nM.
Delamanid-D4 is deuterium-labeled Delamanid. Delamanid (T4202) is a newer mycobacterial cell wall synthesis inhibitor that inhibits the synthesis of mucus acid.
Etravirine (T2551) is a non-nucleoside reverse transcriptase inhibitor (NNRTI)used for the treatment of HIV. Etravirine-D4 is the deuterium labeled Etravirine.
Hydroxyzine-D4 is a deuterium-labeled variation of Hydroxyzine,a chemical compound known for its anticholinergic,anxiolytic,and analgesic properties. It is classified as a heterocyclic histamine H1-receptor antagonist.
Imatinib-D4 is a deuterium-labeled Imatinib. Imatinib (T6230) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL,PDGFR,v-Abl,and c-kit kinase activity.
Indomethacin-D4 is a deuterium labeled Indomethacin. Indomethacin (T0458) is a potent and nonselective inhibitor of COX1 and COX2,with IC50s of 18 nM and 26 nM for human COX-1 and COX-2,respectively,in CHO cells.
Lansoprazole Sulfide-D4 is a deuterium labeled Lansoprazole Sulfide. Lansoprazole Sulfide (T21128) is an orally active anti-TB (Mycobacterium tuberculosis)agent with IC50 values of 0.59 μM intracellularly and 0.46 μM in broth.Lansoprazole Sulfide is an active metabolite of the proton pump inhibitor Lansoprazole.